Nutritional management in MND/ALS patients: An evidence based review

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 5, Issue 2, 2004, Pages 72-83

  Heffernan, Catherine ^a   Jenkinson, Crispin ^a   Holmes, Tricia ^b   Feder, Gene ^c   Kupfer, Richard ^d   Leigh, P Nigel ^e   McGowan, Sue ^f   Rio, Alan ^e   Sidhu, Paul ^g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Motor Neurone Disease Association   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; LAXATIVE; THREONINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CRICOPHARYNGEUS MUSCLE; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSPHAGIA; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; FEEDING BEHAVIOR; FLUID INTAKE; FLUOROSCOPY; HUMAN; MALNUTRITION; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDLINE; MOTOR NEURON DISEASE; MYOTOMY; NASOGASTRIC TUBE; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT POSITIONING; PATIENT REFERRAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; REVIEW; SURVIVAL; SYSTEMATIC REVIEW; ANIMAL; DIET THERAPY; METHODOLOGY; PRACTICE GUIDELINE; STANDARD;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DEGLUTITION DISORDERS; ENTERAL NUTRITION; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES;

EID: 3843122180     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820410020349     Document Type: Review

References (92)

1. Cameron R, Rosenfield J. Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders. Current Opinion in Clinical Nutrition and Metabolic Care 2002; 5(6): 631-643.
2. Desport JC. Home artificial nutrition in chronic neurological disorders. Clin Nutrition 2002; 21(1): 97-98.
3. Lacomblez L, Bensimon G, Leigh N, Guillet P, Meininger V. A dose ranging study of riluzole in ALS. Lancet 1996; 347: 1425-1431.
4. Desport JC, Preux PM, Magy L et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. A J Clin Nutrition 2001; 74(3): 328-334.
5. Kasarskis EJ, Berryman S, Vanderlees JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. A J Clin Nutrition 1996; 63(1): 130-137.
6. Silani V, Kasarskis EJ, Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. J Neurology 1998; 245(Suppl 2): S13-19.
7. Miller RG, Rosenberg JA, Gelinas DF et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review). Neurology 1999; 52: 1311-1323.
8. Moxley RT, Kempf C. Nutritional Management. In: Mulder DW (ed.) The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis. Boston, Massachusets: Houghton Mifflin Professional Publishers, 1998: 269-290.
9. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. 1999, "Nutritional status is a prognostic factor for survival in ALS patients", Neurology 1999; 53(5): 1059-1063.
10. Robbins J. Swallowing in ALS and motor neuron disorders. Neurological Clinics 1987; 5: 213-229.
11. Borasio GD, Shaw PJ, Hardiman O, Ludolph AC, Sales-Luis ML, Silani V. Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2001; 2(3): 159-164.
12. Langmore SE, Winterholler M-G M, Erbguth FJ et al. Issues in the management of dysphagia. Folia Phoniatrica et Logopaedica 1999; 51(4-5): 220-230.
13. Houde SC, Mangolds V. Amyotrophic lateral sclerosis: a team approach to primary care. Clin Excell Nurse Pract 1999; 3(6): 337-345.
14. Carter GT, Miller RG. Comprehensive management of amyotrophic lateral sclerosis. Physical Medicine and Rehabilitation Clinics of North America 1998; 9(1): 271-284.
15. Harding SM. Oropharyngeal dysfunction in COPD patients: the need for clinical research. Chest 2001; 121(2): 315-317.
16. Scott A, Heughan A. A review of dysphagia in four cases of mom neurone disease. Palliative Medicine 1993; 7 (Suppl 4): 41-47.
17. Mitsumoto H, Chad DA, Pioro EP. Nutritional management. In: Mitsumoto H, Chad DA, Pioro E (eds.) Amyotrophic Lateral Sclerosis. Philadelphia: Davis, 1998: 421-436.
18. Hillel AD, Miller RM. Management of bulbar symptoms in amyotrophic lateral sclerosis. Advances in Experimental Medicine and Biology 1987; 209: 201-221.
19. Gelinas DF, Miller RG. A treatable disease: a guide to the management of amyotrophic lateral sclerosis. In: Brown R, Meininger V, Swash M (eds.) Amyotrophic Lateral Sclerosis, London: Martin Dunitz, 2000: 405-421.
20. Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurology 2000; 247(4): 245-251.
21. Desport JC, Preux PM, Truong CT, Courat L, Valla JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000; 1(2): 91-96.
22. Higo R, Tayama N, Watanabe T, Nitou T. Videomanofluorometric study in amyotrophic lateral sclerosis. Laryngoscope 2002; 112(5): 911-917.
23. Cheldi A, Perin M, Mazzucchelli F et al. Amyotrophic lateral sclerosis: a dynamic study of deglutition. Riv Neurobiologia 1999; 45(5-6): 459-463.
24. Chen MY, Peele VN, Donati D, Ott DJ, Donofrio PD, Gelfand DW. Clinical and videofluoroscopic evaluation of swallowing in 41 patients with neurologic disease. Gastrointestinal Radiology 1992; 17(2): 95-98.
25. Wilson PS, Bruce-Lockhart FJ, Johnson AP. Videofluoroscopy in motor neurone disease prior to cricopharyngeal myotomy. Annals of the Royal College of Surgeons of England 1990; 72(6): 375-377.
26. Bevan K, Griffiths MV. Chronic aspiration and laryngeal competence. J Laryngol Otol 2001; 103(2): 196-199.
27. Sufit R. Symptomatic treatment of ALS. Neurology 1997; 48 (Suppl 4): S22.
28. Briani C, Marcon M, Ermani M et al. Radiological evidence of subclinical dysphagia in motor neurone disease. J Neurol 1998; 245(4): 211-216.
29. Ertekin C, Aydogdu I, Yuceyar N et al. Electrodiagnostic methods for neurogenic dysphagia. Electroencephalography and Clinical Neurophysiology 1998; 109(4): 331-340.
30. Leigh PN, Williams V, Abrahams S. Clinical management. Motor neurone disease. European Journal of Palliative Care 2001; 8(1): 10.
31. Langton Hewer R, Enderby P. Bulbar dysfunctions. In: Clifforrd-Rose F (ed.) Amyotrophic Lateral Sclerosis. New York: Vol 1. Demos, 1990, 99-107.
32. Leigh PN, Ray-Chaudhuri K. Motor neurone disease. Journal of Neurology, Neurosurgery and Psychiatry 1994; 75(8): 886-896.
33. Sonies BC. Patterns of care for dysphagic patients with degenerative neurological diseases. Seminars in Speech and Language 2000; 21(4): 333.
34. Buchholz DW. Cricopharyngeal myotomy may be effective treatment for selected patients with neurogenic oropharyngeal dysphagia. Dysphagia 1995; 10(4): 255-258.
35. Loizou LA, Small M, Dalton GA. Cricopharyngeal myotomy in motor neurone disease. Journal of Neurology, Neurosurgery and Psychiatry 1980; 43(1): 42-45.
36. David VC. Relief of dysphagia in motor neurone disease with cricopharyngeal myotomy. Annals of the Royal College of Surgeons of England 1985; 67(4): 229-231.
37. Tayama N. Dysphagia in amyotrophic lateral sclerosis: the mechanism and managements. Rinsho Shinkeigaku 1995; 35(12): 1557-1559.
38. Janzen VD, Rae FE, Hudson AJ. Otolaryngological manifestations of amyotrophic lateral sclerosis. Journal of Otolaryngology 1988; 17(1): 41-42.
39. Stalpers LJA, Moser E. Results of radiotherapy for drooling in amyotrophic lateral sclerosis. Neurology 2002; 58(8): 1308.
40. Harriman M, Morrison M, Hay J, Revonta. M, Eisen A, Lentle B. Use of radiotherapy for control of sialorrhoea in patients with amyotrophic lateral sclerosis. Journal of Otolaryngology 2001; 30(4): 242-245.
41. Anderson PM, Gronberg H, Franzen L, Funegard U. External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis. Journal of Neurological Sciences 2001; 191: 111-114.
42. Bushara KO. Sialorrhoean amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin injection of the parotoid gland. Medical Hypotheses 1997; 48: 337-339.
43. Giess R, Naumann M, Werner E et al. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2000; 69(1): 121-123.
44. Burns BL, Carr-Davies EM. Nutritional care in diseases of the nervous system. In: Mahan L, Escott-Stump S (eds.) Krause's Food, Nutrition, and Diet Therapy, 9th edn. Philadelphia: Saunders, 1996: 863-888.
45. Kristjanson LJ, Nelson F, Henteleff P. Palliative care for individuals with amyotrophic lateral sclerosis. J Palliative Care 1987; 2(2): 28-34.
46. Hudson A-J J. Outpatient management of amyotrophic lateral sclerosis. Seminars in Neurology 1987; 7(4): 344-351.
47. Buchholz DW. Dysphagia associated with neurological disorders. Acta Otorhinolaryngol Belg 1994; 48(2): 143-155.
48. Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neurol 2001; 21(2): 155-166.
49. Palmo A, Bianco L, Protta F, Galletti R, Finocchiaro, C. Home artificial nutrition in chronic neurological disorders. Clin Nutrition 2001; 20 (Suppl 2): 29-33.
50. Worwood AM, Leigh PN. Indicators and prevalence of malnutrition in motor neurone disease. Eur Neurol 1988; 40(3): 159-163.
51. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242(10): 695-698.
52. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1996; 53(5): 1059-1063.
53. Willig TN, Bach JR, Venance V, Navarro J. Nutritional rehabilitation in neuromuscular disorders. Semin Neurol 1995; 15(1): 18-23.
54. Slowie LA, Paige MS, Antel JP. Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc 1983; 83(1): 44-47.
55. Nau KL, Dick AR, Peters K, Schloerb PR. Relative validity of clinical techniques for measuring the body composition of persons with amyotrophic lateral sclerosis. Journal of Neurological Sciences 1997; 152 (Suppl 1): S36-42.
56. Nau KL, Bromberg MD, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995; 129 (suppl): 47-49.
57. Kanda F, Fujii Y, Takahashi K, Fujita T. Dual-energy X-ray absorptiometry in neuromuscular diseases. Muscle and Nerve 1994; 17(4): 431-435.
58. Tandan R, Krusinki PB, Hiser JR. The validity and sensitivity of dual energy X-ray absorptiometry in estimating lean body mass in amyotrophic lateral sclerosis. Proceedings of the 9th International Symposium on ALS/MND 1998: 48.
59. Hillinger M, White L, Forshew D, Oiney R, Lomen-Hoerth C. Weight loss in ALS: malnutrition or disease progression? Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002; 3 (Suppl 2): S36-37.
60. Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Clin Neurol 1991; 31: 255-259.
61. Sato Y, Honda Y, Asoh T, Kikuyama M, Oizumi K. Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. European Neurology 1997; 37(4): 225-229.
62. Burns BL, Carr-Davies E. Nutritional care in diseases of the nervous system. In: Mahan LK, Escott-Stump L (eds.) Krause's Food, Nutrition, and Diet Therapy, 9th edn. Philadelphia: Saunders, 1996: 863-888.
63. Stanich P, Chiapetta A, Oliveria A, Gabbai A. Nutritional supplements in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002; 3 (Suppl 2): 119.
64. Toepfer M, Schroeder M, Klauser A et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res 1997; 2(11): 473-476.
65. Toepfer M, Folwaczny C, Lochmuller H et al. Non-invasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion 1999; 60(6): 567-571.
66. Corden E. Better nutrition in neurological disorders. Community Nurse 1996; 2(9): 30-32.
67. Evans J, Shaw PJ. Motor neurone disease: 2. Management of the condition. The Pharmaceutical Journal 2001; 267: 714-717,
68. Langton-Hewer R. The management of motor neurone disease. In: Leigh PN, Swash M (eds.) Motor Neurone Disease: Biology and Management. London: Springer-Verlag, 1995: 375-406.
69. DeLisa JA, Mikulic MA, Miller RM, Melnick RR. Amyotrophic lateral sclerosis: comprehensive management. American Family Physician 1979; 19(3): 137-142.
70. Rose FC. The management of motor neurone disease. Advances in Experimental Medicine and Biology 1987; 209(167): 174.
71. Borasio GD. Amyotrophic lateral sclerosis: symptomatic treatment and experimental therapies. Munchener Medicinische Wochenschrift 1994; 136(19): 55-64.
72. Park RH, Allison MC, Lang J. Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. Br Med J 1992; 304: 1406-1409.
73. Strong MJ, Rowe A, Rankin RN. Percutaneous; gastrojejunostomy in amyotrophic lateral sclerosis. J Neurol Sci 1999; 169(1-2): 128-132.
74. Thornton FJ, Fotheringham T, Alexander M, Hardiman O, McGrath FP, Lee MJ. Amyotrophic lateral sclerosis: enteral nutrition provision - endoscopic or radiologic gastrostomy? Radiology 2002; 224(3): 713-717.
75. Finocchiaro, E, Da Point MC, Chio A, Rivetti M, Onorati P, Rovera GM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis. Clin Nutrition 1998; 17 (Suppl 1): 37.
76. Chio A, Finocchiaro, E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology 1999; 53(5): 1123-1125.
77. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999; 169(1-2): 118-125.
78. Boitano LJ, Jordan T, Benditt JO. Non-invasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology 2001; 56(3): 413-414.
79. Gregory S, Siderowf A, Golaszewski AL, McCluskey L. Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology 2002; 58(3): 485-487.
80. Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney-de-Jong JM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc 1994; 40(4): 463-469.
81. Britton JER, Lipscomb G, Mohr PD, Ress WD, Young AC. The issue of percutaneous endoscopic gastrostomy (PEG) feeding tubes in patients with neurological disease. Journal of Neurology 1997; 244: 431-434.
82. Louwerse ES, Mathus-Vliegen EMH, Merkus MP, Tytgat GN, Jong JM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis. Procedure Related Mortality and Its Effect on Survival. Journal of Neurology 1995; 244 (Suppl 3): S15.
83. Del Piano M, Montino F, Occhipinti P, D'Andrea F. Percutaneous endoscopic gastrostomy: methods and personal findings. Acta Endoscopica 1995; 23(3): 246.
84. Rozier A, Roskone-Fourmestraux A, Rosenbaum A, Delvigne JM, Besancon F, Meininger V. Place de la gastrostomie endoscopique percutanee dans la sclerose laterale amyotrophique. Revue de Neruologie de Paris 1991; 147(2): 174-176.
85. Cortez-Pinto H, Pinto Correia A, Camilo ME, Tavares L, Carneiro De Moura M. Long term management of percutaneous endoscopic gastrostomy by a nutritional support team. Clinical Nutrition 2002; 21(1): 27-31.
86. Chio A, Galletti R, Finocchiaro C et al. Radiologically inserted gastrostomy (RIG): a safe and effective alternative to traditional PEG in advanced ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002; 3 (Suppl 2): S37.
87. Wollman B, D'Agostino HB, Walus-Wigle JR, Easter DW, Beale A. Radiologic, endoscopic and surgical gastrostomy: an institutional evaluation and meta analysis of the literature. Radiology 1995; 197: 699-704.
88. Scott AG, Austin HE. Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliative Medicine 1994; 8(1): 45-49.
89. Ehler E, Geier P, Vyhnalek P, Hajek J, Sakra L. Dysphagia in patients with disorders of the nervous system: comparsion of a nasogastric tube with percutaneous endoscopic gastrostomy, Rozhledy v chirurgii mesicnikCeskoslovenske Chirurgicke Spolecnosti 2002; 81(6): 316-319.
90. Albert SM, Murphy PL, Del Bene M, Rowland LP, Mitsumoto H. Incidence and predictors of PEG placement in ALS/MND. J Neurol Sci 2001; 191: 115-119.
91. Albert SM, Murphy PL, Del Bene ML, Rowland LP. A prospective study of preferences and actual treatment choices in ALS. Neurology 1999; 53: 278-283.
92. Smith RA, Norris Jr FH. Symptomatic care of patients with amyotrophic lateral sclerosis, JAMA 1975; 234: 715-717.